ReP USP - Resultado da busca

Artigo de periodico
Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models (2025)
Simonsen, Marcelo; Lopez, Rossana Veronica Mendoza; Maistro, Simone; Ikeoka, Lucas Takeshi; Pereira, Glaucia Fernanda de Lima; Lugao, Ademar Benevolo; Sadalla, Jose Carlos; Katayama, Maria Lúcia Hirata ; Folgueira, Maria Aparecida Azevedo Koike
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: REVISÃO SISTEMÁTICA, QUIMIOTERAPIA, NEOPLASIAS UTERINAS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONSEN, Marcelo et al. Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models. Frontiers in oncology, v. 14, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82782. Acesso em: 09 nov. 2025.
APA
Simonsen, M., Lopez, R. V. M., Maistro, S., Ikeoka, L. T., Pereira, G. F. de L., Lugao, A. B., et al. (2025). Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models. Frontiers in oncology, 14. doi:10.3389/fonc.2024.1487376
NLM
Simonsen M, Lopez RVM, Maistro S, Ikeoka LT, Pereira GF de L, Lugao AB, Sadalla JC, Katayama MLH, Folgueira MAAK. Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models [Internet]. Frontiers in oncology. 2025 ; 14[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82782
Vancouver
Simonsen M, Lopez RVM, Maistro S, Ikeoka LT, Pereira GF de L, Lugao AB, Sadalla JC, Katayama MLH, Folgueira MAAK. Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models [Internet]. Frontiers in oncology. 2025 ; 14[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82782
Artigo de periodico-carta/editorial
Lipids, lipid oxidation, and cancer. [Editorial]: from biology to therapeutics (2024)
Bydlowski, Sérgio Paulo ; Poirot, Marc
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: LIPÍDEOS, NEOPLASIAS DO COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BYDLOWSKI, Sérgio Paulo e POIROT, Marc. Lipids, lipid oxidation, and cancer. [Editorial]: from biology to therapeutics. Frontiers in oncology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76811. Acesso em: 09 nov. 2025. , 2024
APA
Bydlowski, S. P., & Poirot, M. (2024). Lipids, lipid oxidation, and cancer. [Editorial]: from biology to therapeutics. Frontiers in oncology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. doi:10.3389/fonc.2024.1414992
NLM
Bydlowski SP, Poirot M. Lipids, lipid oxidation, and cancer. [Editorial]: from biology to therapeutics [Internet]. Frontiers in oncology. 2024 ; 14[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76811
Vancouver
Bydlowski SP, Poirot M. Lipids, lipid oxidation, and cancer. [Editorial]: from biology to therapeutics [Internet]. Frontiers in oncology. 2024 ; 14[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76811
Artigo de periodico
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades (2023)
Carvalho, Filomena Marino
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, ESTRATÉGIAS TERAPÊUTICAS, PROGNÓSTICO, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Filomena Marino. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57524. Acesso em: 09 nov. 2025.
APA
Carvalho, F. M. (2023). Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1244781
NLM
Carvalho FM. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57524
Vancouver
Carvalho FM. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57524
Artigo de periodico
Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances (2023)
Lage, Luis Alberto de Padua Covas; Culler, Hebert Fabricio; Reichert, Cadiele Oliana; Siqueira, Sheila Aparecida Coelho ; Pereira, Juliana
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: LINFOMA, QUIMIOTERAPIA, FENÓTIPOS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAGE, Luis Alberto de Padua Covas et al. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53787. Acesso em: 09 nov. 2025.
APA
Lage, L. A. de P. C., Culler, H. F., Reichert, C. O., Siqueira, S. A. C., & Pereira, J. (2023). Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1177590
NLM
Lage LA de PC, Culler HF, Reichert CO, Siqueira SAC, Pereira J. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53787
Vancouver
Lage LA de PC, Culler HF, Reichert CO, Siqueira SAC, Pereira J. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53787
Artigo de periodico
Mycosis fungoides and Sezary syndrome: clinical presentation, diagnosis, staging, and therapeutic management (2023)
Miyashiro, Denis Ricardo ; Sanches Junior, Jose Antonio
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS CUTÂNEAS, MICOSES, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYASHIRO, Denis Ricardo e SANCHES JUNIOR, Jose Antonio. Mycosis fungoides and Sezary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53888. Acesso em: 09 nov. 2025.
APA
Miyashiro, D. R., & Sanches Junior, J. A. (2023). Mycosis fungoides and Sezary syndrome: clinical presentation, diagnosis, staging, and therapeutic management. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1141108
NLM
Miyashiro DR, Sanches Junior JA. Mycosis fungoides and Sezary syndrome: clinical presentation, diagnosis, staging, and therapeutic management [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53888
Vancouver
Miyashiro DR, Sanches Junior JA. Mycosis fungoides and Sezary syndrome: clinical presentation, diagnosis, staging, and therapeutic management [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53888
Artigo de periodico
The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer (2023)
Campos, Amarilis de Lima; Sawada, Maria Isabela Bloise Alves Caldas; Santana, Monique Fatima de Mello; Iborra, Rodrigo Tallada; Assis, Sayonara Ivana Santos de; Reis, Mozania; Carvalho, Jacira Xavier de; Gebrim, Luiz Henrique; Passarelli, Marisa
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: COLESTEROL, NEOPLASIAS MAMÁRIAS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Amarilis de Lima et al. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52835. Acesso em: 09 nov. 2025.
APA
Campos, A. de L., Sawada, M. I. B. A. C., Santana, M. F. de M., Iborra, R. T., Assis, S. I. S. de, Reis, M., et al. (2023). The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1111094
NLM
Campos A de L, Sawada MIBAC, Santana MF de M, Iborra RT, Assis SIS de, Reis M, Carvalho JX de, Gebrim LH, Passarelli M. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52835
Vancouver
Campos A de L, Sawada MIBAC, Santana MF de M, Iborra RT, Assis SIS de, Reis M, Carvalho JX de, Gebrim LH, Passarelli M. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52835
Artigo de periodico
Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? (2023)
Couto, Samuel Campanelli Freitas ; Kowes, Ariel; Aurabi, Camila Said; Oliveira, Theo Gremen Mimary ; Klinger, Paulo Henrique dos Santos ; Rocha, Vanderson Geraldo
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: LEUCEMIA, IMUNOTERAPIA, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTO, Samuel Campanelli Freitas et al. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56001. Acesso em: 09 nov. 2025.
APA
Couto, S. C. F., Kowes, A., Aurabi, C. S., Oliveira, T. G. M., Klinger, P. H. dos S., & Rocha, V. G. (2023). Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? Frontiers in oncology, 13. doi:10.3389/fonc.2023.1195759
NLM
Couto SCF, Kowes A, Aurabi CS, Oliveira TGM, Klinger PH dos S, Rocha VG. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56001
Vancouver
Couto SCF, Kowes A, Aurabi CS, Oliveira TGM, Klinger PH dos S, Rocha VG. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56001
Artigo de periodico
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? (2023)
Costa, Renata de Oliveira ; Pereira, Juliana ; Lage, Luis Alberto de Padua Covas ; Baiocchi, Otávio César Guimarães
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: LINFOMA, HERPESVIRUS 4 HUMANO, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Renata de Oliveira et al. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54568. Acesso em: 09 nov. 2025.
APA
Costa, R. de O., Pereira, J., Lage, L. A. de P. C., & Baiocchi, O. C. G. (2023). Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? Frontiers in oncology, 13. doi:10.3389/fonc.2023.1175545
NLM
Costa R de O, Pereira J, Lage LA de PC, Baiocchi OCG. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54568
Vancouver
Costa R de O, Pereira J, Lage LA de PC, Baiocchi OCG. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54568
Artigo de periodico
The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients (2022)
Llera, Andrea Sabina; Abdelhay, Eliana Saul Furquim Werneck; Artagaveytia, Nora; Daneri-Navarro, Adrian; Muller, Bettina; Velazquez, Carlos; Alcoba, Elsa B; Alonso, Isabel; Quinta, Daniela B. Alves da; Nagai, Maria Aparecida
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, RECIDIVA LOCAL DE NEOPLASIA, HETEROGENEIDADE, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LLERA, Andrea Sabina et al. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.835626. Acesso em: 09 nov. 2025.
APA
Llera, A. S., Abdelhay, E. S. F. W., Artagaveytia, N., Daneri-Navarro, A., Muller, B., Velazquez, C., et al. (2022). The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, 12. doi:10.3389/fonc.2022.835626
NLM
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Vancouver
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Artigo de periodico
Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women (2022)
Almeida, Liz Maria de; Cortes, Sandra; Vilensky, Marta; Valenzuela, Olivia; Cortes-Sanabria, Laura; Souza, Mirian de; Barbeito, Rafael Alonso; Abdelhay, Eliana; Artagaveytia, Nora; Nagai, Maria Aparecida
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, FATORES SOCIOECONÔMICOS, MULHERES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Liz Maria de et al. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.845527. Acesso em: 09 nov. 2025.
APA
Almeida, L. M. de, Cortes, S., Vilensky, M., Valenzuela, O., Cortes-Sanabria, L., Souza, M. de, et al. (2022). Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, 12. doi:10.3389/fonc.2022.845527
NLM
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Vancouver
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Artigo de periodico
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions (2022)
Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez; Machado-Rugolo, Juliana; Miranda, Jurandir Tomaz de; Oliveira, Lizandre Keren Ramos de; Velosa, Ana Paula Pereira; Teodoro, Walcy Paganelli Rosolia ; Ab'Saber, Alexandre Muxfeldt; Takagaki, Teresa; Capelozzi, Vera Luiza
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: MATRIZ EXTRACELULAR, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDAVIRA, Camila Machado et al. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/51617. Acesso em: 09 nov. 2025.
APA
Baldavira, C. M., Prieto, T. G., Machado-Rugolo, J., Miranda, J. T. de, Oliveira, L. K. R. de, Velosa, A. P. P., et al. (2022). Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in oncology, 12. doi:10.3389/fonc.2022.1042766
NLM
Baldavira CM, Prieto TG, Machado-Rugolo J, Miranda JT de, Oliveira LKR de, Velosa APP, Teodoro WPR, Ab'Saber AM, Takagaki T, Capelozzi VL. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51617
Vancouver
Baldavira CM, Prieto TG, Machado-Rugolo J, Miranda JT de, Oliveira LKR de, Velosa APP, Teodoro WPR, Ab'Saber AM, Takagaki T, Capelozzi VL. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions [Internet]. Frontiers in oncology. 2022 ; 12[citado 2025 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51617
Artigo de periodico
Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era (2020)
Civantos, Francisco J; Vermorken, Jan B; Shah, Jatin P; Rinaldo, Alessandra; Suarez, Carlos; Kowalski, Luiz Paulo ; Rodrigo, Juan P; Olsen, Kerry; Strojan, Primoz; Makitie, Antti A
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS DE CABEÇA E PESCOÇO, HPV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIVANTOS, Francisco J et al. Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era. Frontiers in oncology, v. 10, 2020Tradução . . Disponível em: https://doi.org/10.3389/fonc.2020.593164. Acesso em: 09 nov. 2025.
APA
Civantos, F. J., Vermorken, J. B., Shah, J. P., Rinaldo, A., Suarez, C., Kowalski, L. P., et al. (2020). Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era. Frontiers in oncology, 10. doi:10.3389/fonc.2020.593164
NLM
Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suarez C, Kowalski LP, Rodrigo JP, Olsen K, Strojan P, Makitie AA. Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era [Internet]. Frontiers in oncology. 2020 ; 10[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2020.593164
Vancouver
Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suarez C, Kowalski LP, Rodrigo JP, Olsen K, Strojan P, Makitie AA. Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era [Internet]. Frontiers in oncology. 2020 ; 10[citado 2025 nov. 09 ] Available from: https://doi.org/10.3389/fonc.2020.593164

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Agência de fomento